Berberine is a bitter, bright-yellow plant alkaloid, the active compound in the Chinese herb Huang Lian, which Chinese medicine has used for centuries to clear Damp-Heat in stubborn digestive and infectious complaints. In people with type 2 diabetes it lowers HbA1c by about 0.6 to 0.9 percentage points and fasting glucose by about 15 mg/dL (0.8 mmol/L), close to metformin in the small head-to-head trials done so far, and it lowers LDL cholesterol by about 18–25 mg/dL (0.5 mmol/L) and triglycerides alongside.
Those effects are smaller and far less studied than the viral 'nature's Ozempic' label implies, and the trials behind them are mostly small, short, and from one region. Berberine also raises the blood levels of many prescription drugs by slowing the enzymes that clear them, and it adds to the effect of diabetes medication, so anyone on medication should weigh the interactions gathered in the cautions below before starting.
Findings & Outcomes
What It Is
Berberine is a plant alkaloid, a bitter, bright-yellow compound found in Chinese goldthread (Coptis, the herb Huang Lian), barberry, Oregon grape, and goldenseal. It has been used in Chinese and other traditional systems for centuries, mostly for digestive complaints and infection. Modern interest has settled on its effect on metabolism: taken as a supplement, it lowers blood sugar and improves the blood-fat picture by a modest, measurable amount.
Anatomy of the Practice
1In the gut
Very little berberine is absorbed, under about 1% of a dose, so a large share of it stays in the gut and acts there, including on the gut bacteria. This poor absorption is why it is split through the day and taken with meals.
2In the liver and muscle
The fraction that does get in mildly blocks a step in the cell energy chain, which activates AMPK, an energy-sensing switch. That is the same target metformin acts on, and it improves how the body handles glucose and lipids.
3On the LDL receptor
In liver cells berberine increases the number of LDL receptors, the receptors that pull cholesterol out of the blood, by a route separate from statins. This is how it lowers LDL, and it is shown mainly in cell and animal work so far.
What It Does
Two kinds of finding sit below, on very different evidence. The metabolic effects, on blood sugar first and blood fats alongside, come from human trials in people with type 2 diabetes and carry the numbers. The mechanism findings, on how berberine reaches AMPK and the LDL receptor, come from cell and animal work and explain why the human effects look the way they do.
The blood-sugar effect is the best studied, so it leads; the cholesterol and triglyceride effects come from the same metabolic action and sit below it. All of them draw on one limited base of trials that are mostly small, short, and run in a single region, of uneven quality. That shared limit applies to all of them, and it is why every figure here is best read as a direction, not a precise value.
The Research & Studies
Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.
Evidence And Methods
The diabetes evidence is mostly small, short, single-country trials
The evidence that berberine lowers blood sugar leans on many small studies from one part of the world, of mixed quality. That does not make it wrong, but it means the size of the effect could shrink when larger, better-run trials are done.
The meta-analyzes that produce berberine's glucose numbers (Lan 2015, Xie 2022) draw almost entirely on trials run in China, many small and short, with limited blinding and allocation detail and high between-study heterogeneity. Reviewers repeatedly flag these limits. Small positive trials also reach print more readily than small null ones, which can lift a pooled average above the truth.
Who this may not transfer to:This is a claim about the quality of the evidence base, not a measured outcome in people.
The studies · 2
Lan et al., Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension · J Ethnopharmacol 2015
Xie et al., Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis · Front Pharmacol 2022
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
Cholesterol And Lipids
Lowers LDL cholesterol about 18–25 mg/dL (0.5 mmol/L)
Berberine brought LDL, the cholesterol linked to heart disease, down by a modest but real amount in the trials, in the same ballpark as its effect on total cholesterol.
Dong and colleagues (2013) pooled 11 randomized trials in 874 participants and found berberine reduced total cholesterol (about 24 mg/dL (0.61 mmol/L)), LDL cholesterol (about 25 mg/dL (0.65 mmol/L)) and triglycerides versus control. Blais and colleagues (2023) confirmed the reductions in a larger meta-analysis of placebo-controlled trials (LDL about 18 mg/dL (0.46 mmol/L); total cholesterol about 19 mg/dL (0.48 mmol/L)) and, examining sex, found the difference between men and women was mainly in HDL cholesterol rather than in LDL. The size is meaningful but smaller and far less studied than a standard statin.
Who this may not transfer to:Blais 2023 found the main sex difference was in HDL cholesterol; the LDL reduction was similar in men and women.
For someone with borderline lipids who wants a diet-and-lifestyle-adjacent option, this is a meaningful effect worth discussing with a clinician. It is not a reason to stop or refuse a statin where one is indicated, and berberine can raise statin levels if the two are combined (see the cautions).
The studies · 2
Dong et al., The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials · Planta Med 2013
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
Lowers triglycerides about 30–44 mg/dL (0.34–0.50 mmol/L)
Berberine also nudged triglycerides down, the blood fat that tracks with metabolic problems, by a small but consistent amount in the trials.
The same meta-analyzes that measured cholesterol (Dong 2013, Blais 2023) reported a reduction in triglycerides with berberine versus control, about 30–44 mg/dL (0.34–0.50 mmol/L). The triglyceride change tends to move in step with the glucose and cholesterol effects, which fits berberine acting on a shared metabolic pathway rather than on lipids alone.
Who this may not transfer to:Drawn from mixed-sex trials; the triglyceride effect has not been separately established for women alone.
The lipid and glucose effects cluster together, so berberine is best thought of as a mild metabolic agent rather than a targeted triglyceride treatment. Anyone with very high triglycerides needs a clinician-directed plan, not a supplement on its own.
The studies · 2
Dong et al., The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials · Planta Med 2013
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
How it works
Under about 1% of an oral dose is absorbed
Almost none of a berberine dose gets into the blood, under about 1%, because the gut and liver break it down first. That is why it is taken several times a day, and why a lot of its effect may come from what it does inside the gut.
Liu and colleagues (2010) traced berberine's very low plasma levels in rats to extensive intestinal first-pass elimination and heavy distribution into the liver, so little intact berberine circulates. This poor bioavailability shapes how it is dosed (split through the day) and points to gut-level effects, including on the microbiome, as part of how it works.
The study · 1
Liu et al., Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats · Drug Metab Dispos 2010
Raises liver LDL receptors to clear more cholesterol, a route unlike statins
Berberine appears to make liver cells display more of the receptors that pull LDL out of the blood, a different mechanism from statins. This is lab and animal evidence explaining the human cholesterol effect.
Kong and colleagues (2004) showed in cultured human liver cells, in hyperlipidemic hamsters, and in a group of hypercholesterolemic patients that berberine upregulates the LDL receptor by stabilizing its messenger RNA through an ERK-dependent pathway, rather than by blocking cholesterol synthesis the way statins do. Because the mechanisms differ, the authors proposed the two could be complementary. This is mechanistic evidence, not a clinical outcome.
The study · 1
Kong et al., Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins · Nat Med 2004;10(12):1344-1351
Works through AMPK like metformin, not the GLP-1 pathway of Ozempic
The way berberine works on metabolism resembles metformin, through an energy-sensing switch called AMPK, not the gut-hormone pathway that the weight-loss injections use. Mechanistically it works like metformin, not like Ozempic.
Turner and colleagues (2008) showed berberine and its derivative dihydroberberine inhibit mitochondrial respiratory complex I, raising cellular AMP and activating AMP-activated protein kinase (AMPK), which improves insulin action; this is the same target metformin engages. GLP-1 drugs such as semaglutide act on an entirely different system, the incretin receptors that govern appetite and insulin release. The popular 'nature's Ozempic' framing conflates two unrelated mechanisms.
The study · 1
Turner et al., Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMPK and improve insulin action · Diabetes 2008;57(5):1414-1418
Blood Sugar
Lowers HbA1c about 0.6 to 0.9 points in type 2 diabetes
Berberine brought blood sugar down in people with type 2 diabetes, by an amount that looked similar to metformin in the trials done so far. The trials are small and mostly from China, so the true size is less settled than that figure suggests.
Lan and colleagues (2015) pooled 27 randomized trials in 2,569 patients and found berberine lowered fasting and post-meal glucose and HbA1c, with reductions comparable to oral glucose-lowering drugs in head-to-head arms and an added benefit when berberine was combined with those drugs. Xie and colleagues (2022) reached the same direction in a later systematic review and meta-analysis of the glucose-lowering effect. Both reviews note the trials are of limited quality, so the pooled averages carry a wide margin.
Who this may not transfer to:Most berberine diabetes trials do not report a clean sex split, so how evenly the effect applies to women is not established.
This is a meaningful effect, but it comes from short trials in one region. For someone already managing diabetes with medication, berberine is something to add under a clinician's eye and with glucose monitoring, not a swap for a prescribed drug.
The studies · 2
Lan et al., Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension · J Ethnopharmacol 2015
Xie et al., Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis · Front Pharmacol 2022
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
In one 36-person trial, HbA1c fell from 9.5% to 7.5%, close to metformin
In one small trial, berberine dropped long-term blood sugar about as much as metformin over three months. It is the trial most often cited for the metformin comparison, and it is a single, modest study.
Yin, Xing and Ye (2008) ran two studies. In the first, 36 adults with newly diagnosed type 2 diabetes were randomized to berberine or metformin for 3 months; HbA1c fell from 9.5% to 7.5% on berberine, comparable to the metformin arm, alongside drops in fasting and post-meal glucose and in triglycerides. In the second, berberine added to existing treatment in poorly controlled patients improved glucose further.
Who this may not transfer to:A single small trial in one center; the sex breakdown of the randomized arm is not clearly reported.
One 36-person open comparison is where the 'as good as metformin' claim comes from. It supports berberine being active, not berberine replacing a first-line drug with decades of outcome data behind it.
The study · 1
Yin, Xing, Ye, Efficacy of berberine in patients with type 2 diabetes mellitus · Metabolism 2008;57(5):712-717
How It Works
Almost none of berberine is absorbed, and that shapes how it is used. Under about 1% of an oral dose reaches the bloodstream, because the gut wall and liver break it down first. That is why it is dosed several times a day, and why much of its action may happen in the gut itself, on the bacteria there, before any of it crosses into the blood.
The small fraction that does get in works on metabolism through AMPK, the same energy-sensing pathway metformin uses; on cholesterol it works separately, increasing the number of LDL receptors on liver cells so the liver clears more LDL from the blood. For the biology of the pathway it acts on, see insulin and glucose.
Is Berberine "Nature's Ozempic"?
Berberine lowers blood sugar and cholesterol by a modest, measurable amount, and in head-to-head arms in type 2 diabetes its drop in HbA1c has looked close to metformin.
The "nature's Ozempic" label overstates that and points at the wrong drug. Semaglutide and its relatives act on GLP-1, the gut-hormone system that governs appetite and insulin release, and they produce large, reliable weight loss. Berberine's effect on weight is small and inconsistent, and the closest comparison for how it works is metformin, the drug it shares a pathway with.
The metabolic numbers come mostly from small, short trials, many run in China, of uneven quality. Their direction is consistent across reviews; their size is less settled than a single figure suggests and could shift as larger, better-run trials arrive. Berberine is a modest metabolic agent, not the weight-loss drug the comparison implies.
How to Take It
Ways to Do It
The routine is a split daily dose with meals, taken for a few weeks and judged by the numbers. It has one complication to handle first. Berberine raises the blood levels of many prescription drugs and adds to the effect of diabetes medication, so if you take any medication, read the interactions in the cautions below before starting.
The dose used in most trials is roughly 1,000 to 1,500 mg a day, split into 500 mg taken two or three times daily with food. It is split because so little is absorbed at once and because dividing it with meals is easier on the stomach. There is no loading phase and no benefit to a single large dose.
The common side effects are digestive: constipation, loose stools, cramping or a bitter taste. They cluster at larger single doses and usually ease when the dose is split and taken with meals. If it upsets your stomach, drop to the lower end and build up slowly.
The metabolic effects show up over weeks, not days. The useful way to know whether it is doing anything for you is the measurements you can track directly: fasting glucose and HbA1c for blood sugar, a lipid panel for cholesterol and triglycerides, all of which you can order yourself through direct-to-consumer testing or have run in the usual way. Check them before and after a trial period rather than judging by feel. If you take diabetes medication, watch those numbers with whoever manages it so the dose can be adjusted as berberine takes effect.
Go Deeper
- Type 2 diabetes: the condition where berberine's blood-sugar effect is studied most, and where it sits among the options with far stronger evidence.
- Weight and metabolic health: the wider metabolic picture behind the "nature's Ozempic" framing, and what moves it.
- Ketogenic diet: another metabolic approach people try around blood sugar and weight, with its own evidence and limits.
- Metformin: the first-line drug berberine's blood-sugar effect is measured against, with far stronger and longer evidence behind it.
- Cholesterol and lipids: the other outcome berberine moves, and where it sits among the levers that lower LDL.
The Chinese Medicine View
Berberine has a direct place in Chinese medicine, not a lab chemical mapped onto the tradition after the fact. It is the principal active constituent of Huang Lian (Coptis chinensis, Chinese goldthread), one of the most important cold, bitter herbs in the Chinese materia medica, and a major constituent of Huang Bai (Phellodendron) and other yellow, bitter herbs. The plant it comes from has a long, specific place in the pharmacopoeia.
In that tradition Huang Lian is classified as bitter and cold, and its work is to clear Heat and drain Damp-Heat, particularly from the Heart and Stomach: it is used for the red, hot, damp patterns such as certain kinds of dysentery, mouth and tongue sores, irritability and heat in the middle. Its intense bitterness and cold nature are why the classical texts caution against long use in people who are weak, cold, or deficient, since a cold, draining herb can injure the Spleen and Stomach yang.
The whole herb is not the isolated molecule. Huang Lian is a complex herb used within formulas, matched to a pattern, and balanced by other herbs; berberine as a supplement is one purified compound taken at a steady dose regardless of pattern. The classical actions of Huang Lian belong to the herb as the tradition uses it, and they are a different claim from the modern trial evidence for the isolated alkaloid. The link is direct, and it places berberine inside a system that has reasoned about this bitter, cold, gut-acting substance for a long time, without lending the supplement the specific clinical claims that belong to the herb in formula.
Berberine is off-limits in pregnancy, breastfeeding, and newborns, and because it raises the blood levels of many prescription drugs, anyone on medication should clear it with a prescriber before starting.
Cautions For This Practice
Extra restraintEverything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.
Constipation, diarrhea and cramping, usually mild and dose-related
The berberine trials report no serious adverse reactions (Lan 2015); gastrointestinal complaints are the commonly described effects, generally transient and mild and more likely at larger single doses. Splitting the dose and taking it with meals is the standard way to reduce them.Lan et al., Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension
Inhibits CYP3A4 and P-glycoprotein, raising levels of many drugs
Qiu and colleagues (2009) showed in animal pharmacokinetics that berberine raised levels of P-glycoprotein substrates such as digoxin and cyclosporine, without a significant change in CYP3A activity in that study. A 2025 review of berberine's effects on cytochrome P450 (Bathaei 2025) summarizes its inhibition of CYP3A4 and other isoenzymes. Because CYP3A4 and P-glycoprotein between them clear a large fraction of common medications, inhibiting them can raise co-administered drug concentrations.Qiu et al., Effect of berberine on the pharmacokinetics of substrates of CYP3A and P-gpBathaei et al., Effects of Berberis vulgaris, and its active constituent berberine on cytochrome P450: a review
Raises cyclosporine levels about 29% in transplant patients
Wu and colleagues (2005) studied renal transplant recipients on cyclosporine A and found that co-administering berberine increased cyclosporine trough concentrations by about 29% and altered its pharmacokinetics, consistent with berberine inhibiting CYP3A4. Cyclosporine has a narrow therapeutic index, so a change of this size can move a patient from a safe level toward toxicity or, if unmanaged, rejection.Wu et al., Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study
Avoid in pregnancy, breastfeeding and newborns: bilirubin and kernicterus risk
Chan (1993) found berberine displaces bilirubin from albumin far more strongly than phenylbutazone, a known potent displacer, and in rats raised unbound and total serum bilirubin; the paper concludes berberine-containing herbs are best avoided in jaundiced neonates and in pregnancy. In a newborn, rising free bilirubin can cross into the brain and cause kernicterus. Linn and colleagues (2012) later re-examined the hemolysis concern and found traditional-dose Coptis and Phellodendron did not aggravate anemia in adults with chronic blood disorders, while the neonatal and G6PD-deficiency cautions remain the reason to avoid it there.Chan, Displacement of bilirubin from albumin by berberineLinn et al., Berberine-induced haemolysis revisited: safety of Rhizoma coptidis and Cortex phellodendri in chronic haematological diseases
Can push blood sugar too low when added to diabetes medication
The same meta-analyzes that establish berberine's glucose-lowering effect (Lan 2015) also show it adds to the effect of oral diabetes drugs when combined, which is the flip side of the benefit: combined with agents that already lower glucose, or with insulin, the additive drop can reach hypoglycemia. The Yin 2008 trials likewise document meaningful glucose lowering that would compound existing treatment.Lan et al., Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertensionYin, Xing, Ye, Efficacy of berberine in patients with type 2 diabetes mellitus
Do not use in pregnancy, breastfeeding, or in newborns
This is the one firm prohibition. Berberine can displace bilirubin from the blood proteins that carry it and can break down red blood cells, and in a newborn rising free bilirubin can cross into the brain and cause kernicterus, a serious form of brain injury. For that reason berberine and berberine-containing herbs are avoided in pregnancy, during breastfeeding, and in infants. People with G6PD deficiency should also be cautious for the same hemolysis reason.
It interacts with many prescription drugs
Berberine inhibits CYP3A4 and P-glycoprotein, the enzyme and transporter that clear a large share of medications, so it can raise the blood levels of statins, some blood-pressure and heart-rhythm drugs, sedatives, certain blood thinners and immunosuppressants. In transplant patients, adding berberine raised levels of the anti-rejection drug cyclosporine by about 29%, which for a narrow-margin drug is a meaningful shift. If you take any prescription medicine, clear berberine with your prescriber or pharmacist before starting.
It can push blood sugar too low with diabetes medication
Because berberine lowers glucose on its own, taking it alongside insulin, sulfonylureas or other glucose-lowering drugs adds to their effect and can bring blood sugar down too far, into hypoglycemia. This is the direct consequence of the benefit. If you take diabetes medication, berberine should be started and dosed with the clinician who manages it, with blood-sugar monitoring, so the medication can be adjusted rather than the two simply stacking.
Digestive side effects are common
Constipation, diarrhea, abdominal cramping, gas and a bitter taste are the usual complaints. They are generally mild and dose-related, more likely at larger single doses, and they usually settle by splitting the dose, taking it with meals, and starting at the lower end.
Start slow, be smart, read the research, and consult a professional if you have any concerns. This is here to inform your choice, not make it for you.
Common Questions
How much does berberine lower blood sugar?
In pooled randomized trials in people with type 2 diabetes, it lowered HbA1c, the three-month blood-sugar average, by roughly 0.6 to 0.9 percentage points, and fasting glucose by about 15 mg/dL (0.8 mmol/L), a size several reviews described as close to metformin in the studies they compared. These trials are mostly small, short, and from one region, so the effect holds but is less certain than the numbers alone suggest.
Can I take berberine with my other medications?
Not without checking first. Berberine slows CYP3A4 and P-glycoprotein, two systems that clear a large share of prescription drugs, so it can raise their levels, sometimes into an unsafe range. It also adds to diabetes medication. Anyone on a prescription drug, and especially anyone on a narrow-margin drug like cyclosporine, tacrolimus or warfarin, should clear berberine with a prescriber or pharmacist before starting.
How should I take it, and how long until it works?
The trial dose is about 500 mg taken two or three times a day with meals, for a total of roughly 1,000 to 1,500 mg. It is split because so little is absorbed at once and because dividing it with food is gentler on the stomach. The metabolic effects build over weeks, so the way to judge it is to check fasting glucose, HbA1c or a lipid panel before and after a trial period rather than by how you feel.
Is berberine the same as the Chinese herb Huang Lian?
They are closely related but not identical. Berberine is the main active compound in Huang Lian (Coptis), a bitter, cold herb used in Chinese medicine to clear Damp-Heat, so the link is direct. But Huang Lian is a whole herb used within formulas and matched to a pattern, while berberine is one purified molecule taken at a fixed dose. The classical actions belong to the herb as it is traditionally used, which is a different thing from the modern trial evidence for the isolated compound.
Explore Related
Other pages this one connects to, by the evidence they share, the outcomes they touch, and the ground they cover.
All 20 sources on this page independently checked and cross-referenced.
Thomas Dehli, Founder & Editor, Sacred Lotus
Sacred Lotus has published Chinese medicine reference material since 2001. Integrative pages are held to the same standard as the herb and formula library: cite the source, grade the claim at its real strength, and say where the research has not looked. This page is educational and it is not medical advice. Last reviewed and updated August 9, 2026.
Evidence strength
How confidently the research supports a claim. Strength describes the evidence, not our endorsement.